{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:22:38Z","timestamp":1788870158044,"version":"build-2803163510"},"reference-count":64,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,22]],"date-time":"2013-07-22T00:00:00Z","timestamp":1374451200000},"content-version":"vor","delay-in-days":477,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"crossref"}]},{"name":"PRONEX\/CNPq\/FAPERGS"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.pnpbp.2011.11.005","type":"journal-article","created":{"date-parts":[[2011,11,22]],"date-time":"2011-11-22T04:34:35Z","timestamp":1321936475000},"page":"15-21","source":"Crossref","is-referenced-by-count":17,"title":["The potential antidepressant-like effect of imidazoline I2 ligand 2-BFI in mice"],"prefix":"10.1016","volume":"37","author":[{"given":"Raquel","family":"Tonello","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jardel Gomes","family":"Villarinho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"da Silva Sant'Anna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00eddia","family":"Tamiozzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Machado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Trevisan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos Ant\u00f4nio","family":"Pinto Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliano","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maribel Antonello","family":"Rubin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2011.11.005_bb0005","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/PL00005026","article-title":"Labelling of I2B-imidazoline receptors by [3H]2-(2-benzofuranyl)-2-imidazoline (2-BFI) in rat brain and liver: characterization, regulation and relation to monoamine oxidase enzymes","volume":"356","author":"Alemany","year":"1997","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.pnpbp.2011.11.005_bb0010","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1111\/j.1471-4159.2006.03662.x","article-title":"Autoradiographical distribution of imidazoline binding sites in monoamine oxidase A deficient mice","volume":"96","author":"Anderson","year":"2006","journal-title":"J Neurochem"},{"key":"10.1016\/j.pnpbp.2011.11.005_bb0015","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0003-3472(73)80065-X","article-title":"Tests for emotionality in rats and mice: a review","volume":"21","author":"Archer","year":"1973","journal-title":"Anim Behav"},{"key":"10.1016\/j.pnpbp.2011.11.005_bb0020","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1196\/annals.1304.014","article-title":"Is agmatine an endogenous anxiolytic\/antidepressant agent?","volume":"1009","author":"Aricioglu","year":"2003","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.pnpbp.2011.11.005_bb0025","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.neuropharm.2011.07.012","article-title":"Agmatinase, an inactivator of the putative endogenous antidepressant agmatine, is strongly upregulated in hippocampal interneurons of subjects with mood disorders","volume":"62","author":"Bernstein","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2011.11.005_bb0030","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.bbr.2005.06.015","article-title":"A proposal of decision tree to screen putative antidepressants using forced swim and tail suspension tests","volume":"164","author":"Bourin","year":"2005","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pnpbp.2011.11.005_bb0035","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S0022-3565(25)21405-7","article-title":"Central cardiovascular effects of alpha adrenergic drugs: differences between catecholamines and imidazolines","volume":"230","author":"Bousquet","year":"1984","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pnpbp.2011.11.005_bb0040","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0022-3565(25)24461-5","article-title":"Inhibition of amine oxidase activity by derivatives that recognize imidazoline I2 sites","volume":"272","author":"Carp\u00e9n\u00e9","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pnpbp.2011.11.005_bb0045","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0014-2999(90)90568-Q","article-title":"Alpha 2-adrenoceptor blockade prevents the effect of desipramine in the forced swimming test","volume":"175","author":"Cervo","year":"1990","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pnpbp.2011.11.005_bb0060","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1111\/j.1476-5381.1994.tb13191.x","article-title":"The imidazoline site involved in control of insulin secretion: characteristics that distinguish it from I1- and I2-sites","volume":"112","author":"Chan","year":"1994","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pnpbp.2011.11.005_bb0050","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0165-6147(02)02017-5","article-title":"Assessing antidepressant activity in rodents: recent developments and future needs","volume":"23","author":"Cryan","year":"2002","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pnpbp.2011.11.005_bb0055","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.neubiorev.2005.03.009","article-title":"The tail suspension test for assessing antidepressant activity: review of pharmacological and genetic studies in mice","volume":"29","author":"Cryan","year":"2005","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.pnpbp.2011.11.005_bb0065","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/BF00171072","article-title":"Experimental anxiety and antidepressant drugs: the effects of moclobemide, a selective reversible MAO-A inhibitor, fluoxetine and imipramine in mice","volume":"354","author":"De Angelis","year":"1996","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"Suppl. 4","key":"10.1016\/j.pnpbp.2011.11.005_bb0070","first-page":"19","article-title":"The pharmacologic profile of mirtazapine","volume":"57","author":"De Boer","year":"1996","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pnpbp.2011.11.005_bb0075","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/BF02246053","article-title":"Blockade of the antidepressant-like effects of 8 OHDPAT, buspirone and desipramine in the rat forced swim test by 5HT1A receptor antagonists","volume":"119","author":"Detke","year":"1995","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pnpbp.2011.11.005_bb0080","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.pnpbp.2007.08.042","article-title":"Evidence for the involvement of the monoaminergic system in the antidepressant-like action of two 4-amine derivatives of 10,11-dihydro-5H-dibenzo [a, d] cycloheptane in mice evaluated in the tail suspension test","volume":"32","author":"Duarte","year":"2008","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2011.11.005_bb0085","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1001\/archpsyc.1997.01830190015002","article-title":"A molecular and cellular theory of depression","volume":"54","author":"Duman","year":"1997","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pnpbp.2011.11.005_bb0090","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0165-6147(98)01244-9","article-title":"Seeing through a glass darkly: casting light on imidazoline \u201cI\u201d sites","volume":"19","author":"Eglen","year":"1998","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pnpbp.2011.11.005_bb0095","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.pnpbp.2003.11.018","article-title":"Central monoamines and their role in major depression","volume":"28","author":"Elhwuegi","year":"2004","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2011.11.005_bb0100","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1006\/phrs.1997.0275","article-title":"The effects of moclobemide on the yohimbine-induced anxiogenic action in the elevated plus-maze","volume":"37","author":"Ero\u011flu","year":"1998","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.pnpbp.2011.11.005_bb0105","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s00213-003-1392-3","article-title":"Behavioral, neuroendocrine and neurochemical effects of the imidazoline I2 receptor selective ligand BU224 in naive rats and rats exposed to the stress of the forced swim test","volume":"167","author":"Finn","year":"2003","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pnpbp.2011.11.005_bb0115","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1001\/archpsyc.1996.01830090049008","article-title":"Immunodetection and quantitation of imidazoline receptor proteins in platelets of patients with major depression and in brains of suicide victims","volume":"53","author":"Garc\u00eda-Sevilla","year":"1996","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pnpbp.2011.11.005_bb0120","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0304-3940(98)00265-1","article-title":"Imidazoline receptor proteins in brains of patients with Alzheimer's disease","volume":"247","author":"Garc\u00eda-Sevilla","year":"1998","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pnpbp.2011.11.005_bb0110","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1046\/j.1471-4159.1999.0720282.x","article-title":"Up-regulation of immunolabeled alpha2A-adrenoceptors, Gi coupling proteins, and regulatory receptor kinases in the prefrontal cortex of depressed suicides","volume":"72","author":"Garc\u00eda-Sevilla","year":"1999","journal-title":"J Neurochem"},{"key":"10.1016\/j.pnpbp.2011.11.005_bb0125","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ejphar.2004.05.045","article-title":"Alpha 2-adrenoceptors and 5-HT receptors mediate the antinociceptive effect of new pyrazolines, but not of dipyrone","volume":"496","author":"Godoy","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pnpbp.2011.11.005_bb0130","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/00004850-199512004-00003","article-title":"Noradrenergic modulation of central serotonergic neurotransmission: acute and long-term actions of mirtazapine","volume":"4","author":"Haddjeri","year":"1995","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2011.11.005_bb0135","first-page":"409","article-title":"Imidazoline binding sites on receptors and enzymes: emerging targets for novel antidepressant drugs?","volume":"28","author":"Holt","year":"2003","journal-title":"J Psychiatry Neurosci"},{"key":"10.1016\/j.pnpbp.2011.11.005_bb0140","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1111\/j.1742-4658.2007.05704.x","article-title":"Interactions of imidazoline ligands with the active site of purified monoamine oxidase A","volume":"274","author":"Jones","year":"2007","journal-title":"FEBS J"},{"key":"10.1016\/j.pnpbp.2011.11.005_bb0145","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1749-6632.1999.tb09350.x","article-title":"Inhibition of central monoamine oxidase by imidazoline 2 site selective ligands","volume":"881","author":"Lalies","year":"1999","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.pnpbp.2011.11.005_bb0150","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/sj.mp.4000754","article-title":"Selective increase of dopamine D3 receptor gene expression as a common effect of chronic antidepressant treatments","volume":"5","author":"Lammers","year":"2000","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pnpbp.2011.11.005_bb0155","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1007\/s00018-009-0055-x","article-title":"Depression and antidepressants: molecular and cellular aspect","volume":"66","author":"Lanni","year":"2009","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.pnpbp.2011.11.005_bb0160","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0014-2999(96)00131-8","article-title":"[3H]-2-(2-benzofuranyl)-2-imidazoline: a new selective high affinity radioligand for the study of rabbit brain imidazoline I2 receptors","volume":"304","author":"Lione","year":"1996","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pnpbp.2011.11.005_bb0165","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0014-2999(98)00389-6","article-title":"Characterisation and localisation of [3H]2-(2-benzofuranyl)-2-imidazoline binding in the rat brain: a selective ligand for imidazoline I2 receptors","volume":"353","author":"Lione","year":"1998","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pnpbp.2011.11.005_bb0170","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/BF00177912","article-title":"The use of a plus-maze to measure anxiety in the mouse","volume":"92","author":"Lister","year":"1987","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pnpbp.2011.11.005_bb0175","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0304-3940(96)13132-3","article-title":"The \u03b12-adrenoceptor antagonist idazoxan is an agonist at 5-HT1A autoreceptors modulating serotonin synthesis in the rat brain in vivo","volume":"218","author":"Llad\u00f3","year":"1996","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pnpbp.2011.11.005_bb0180","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.pnpbp.2006.11.004","article-title":"Antidepressant-like effect of the extract from leaves of Schinus molle L. in mice: evidence for the involvement of the monoaminergic system","volume":"31","author":"Machado","year":"2007","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2011.11.005_bb0185","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0014-2999(96)00123-9","article-title":"Antidepressant drugs given repeatedly change the binding of the dopamine D2 receptor agonist, [3H]N-0437, to dopamine D2 receptors in the rat brain","volume":"304","author":"Maj","year":"1996","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pnpbp.2011.11.005_bb0190","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S0006-3223(03)00117-3","article-title":"Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for difficult-to-treat depression","volume":"53","author":"Manji","year":"2003","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2011.11.005_bb0195","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/0165-6147(89)90002-3","article-title":"Are there multiple imidazoline binding sites?","volume":"10","author":"Michel","year":"1989","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pnpbp.2011.11.005_bb0200","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.ejphar.2004.07.038","article-title":"The role of monoamines in the actions of established and \u201cnovel\u201d antidepressant agents: a critical review","volume":"500","author":"Millan","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pnpbp.2011.11.005_bb0205","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.pbb.2007.11.001","article-title":"Interaction between cannabinoid compounds and diazepam on anxiety-like behaviour of mice","volume":"89","author":"Naderi","year":"2008","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pnpbp.2011.11.005_bb0210","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1017\/S003329170105434z","article-title":"Dopamine transporter availability in symptomatic depressed patients with seasonal affective disorder and healthy controls","volume":"31","author":"Neumeister","year":"2001","journal-title":"Psychol Med"},{"key":"10.1016\/j.pnpbp.2011.11.005_bb0215","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1749-6632.1995.tb32397.x","article-title":"Functional studies of specific imidazoline-2 receptor ligands","volume":"763","author":"Nutt","year":"1995","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.pnpbp.2011.11.005_bb0220","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1177\/026988110101500104","article-title":"Selective imidazoline I2 ligands do not show antidepressant-like activity in the forced swim test in mice","volume":"15","author":"O'Neill","year":"2001","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2011.11.005_bb0230","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0022-3956(96)00005-2","article-title":"Platelet I1-imidazoline binding sites are elevated in depression but not generalized anxiety disorder","volume":"30","author":"Piletz","year":"1996","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.pnpbp.2011.11.005_bb0225","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jpsychires.2006.10.011","article-title":"Platelet imidazoline receptors as state marker of depressive symptomatology","volume":"42","author":"Piletz","year":"2008","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.pnpbp.2011.11.005_bb0235","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.biopsych.2005.05.042","article-title":"5-Hydroxytryptamine 1A receptors, major depression, and suicidal behavior","volume":"58","author":"Pitchot","year":"2005","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2011.11.005_bb0240","first-page":"327","article-title":"Behavioral despair in mice: a primary screening test for antidepressants","volume":"229","author":"Porsolt","year":"1977","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"10.1016\/j.pnpbp.2011.11.005_bb0245","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1749-6632.1999.tb09376.x","article-title":"Modulation of MAO activity by imidazoline and guanidine derivatives","volume":"881","author":"Raasch","year":"1999","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.pnpbp.2011.11.005_bb0250","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1124\/mol.52.4.549","article-title":"Localization of the imidazoline binding domain on monoamine oxidase B","volume":"52","author":"Raddatz","year":"1997","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pnpbp.2011.11.005_bb0255","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1146\/annurev.pa.36.040196.002455","article-title":"Imidazoline receptors and their endogenous ligands","volume":"36","author":"Regunathan","year":"1996","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.pnpbp.2011.11.005_bb0260","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0893-133X(00)00214-1","article-title":"Idazoxan and 8-OH-DPAT modify the behavioral effects induced by either NA, or 5-HT, or dual NA\/5-HT reuptake inhibition in the rat forced swimming test","volume":"24","author":"R\u00e9n\u00e9ric","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2011.11.005_bb0265","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/PL00005340","article-title":"Effects of antidepressant drugs on dopamine D2\/D3 receptors in the rat brain differentiated by agonist and antagonist binding \u2014 an autoradiographic analysis","volume":"359","author":"Rogoz","year":"1999","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.pnpbp.2011.11.005_bb0270","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0925-4927(00)00076-7","article-title":"Altered 5-HT (2A) binding sites and second messenger inositol trisphosphate (IP(3)) levels in hippocampus but not in frontal cortex from depressed suicide victims","volume":"99","author":"Rosel","year":"2000","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.pnpbp.2011.11.005_bb0275","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.bmcl.2008.03.001","article-title":"Ultrasound promoted synthesis of 2-imidazolines in water: a greener approach toward monoamine oxidase inhibitors","volume":"19","author":"Sant'Anna","year":"2009","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.pnpbp.2011.11.005_bb0280","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0304-3940(01)01599-3","article-title":"The imidazoline receptor ligand 2-(2-benzofuranyl)-2-imidazoline is a dopamine-releasing agent in the rat striatum in vivo","volume":"301","author":"Sastre-Colla","year":"2001","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pnpbp.2011.11.005_bb0285","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/978-1-4899-1813-0_81","article-title":"Dopamine potentiation of calcium ionophore, A 23187-induced platelet aggregation","volume":"407","author":"Shah","year":"1997","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.pnpbp.2011.11.005_bb0290","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/BF00428203","article-title":"The tail suspension test: a new method for screening antidepressants in mice","volume":"85","author":"Steru","year":"1985","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pnpbp.2011.11.005_bb0295","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1126\/science.1117571","article-title":"Alterations in 5-HT1B receptor function by p11 in depression-like states","volume":"311","author":"Svenningsson","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.pnpbp.2011.11.005_bb0300","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.neuropharm.2009.06.035","article-title":"Antidepressant like effect of selective serotonin reuptake inhibitors involve modulation of imidazoline receptors by agmatine","volume":"57","author":"Taksande","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2011.11.005_bb0305","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0021-9258(18)52415-7","article-title":"Subcellular distribution of imidazoline\u2013guanidinium-receptive sites in human and rabbit liver. Major localization to the mitochondrial outer membrane","volume":"266","author":"Tesson","year":"1991","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pnpbp.2011.11.005_bb0325","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0024-3205(96)00639-X","article-title":"Binding of [3H]-2-(2-benzofuranyl)-2-imidazoline (BFI) to human brain: potentiation by tranylcypromine","volume":"60","author":"Wiest","year":"1997","journal-title":"Life Sci"},{"key":"10.1016\/j.pnpbp.2011.11.005_bb0315","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/00001756-200203250-00005","article-title":"Agmatine produces antidepressant-like effects in two models of depression in mice","volume":"13","author":"Zomkowski","year":"2002","journal-title":"Neuroreport"},{"key":"10.1016\/j.pnpbp.2011.11.005_bb0320","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.brainres.2004.07.041","article-title":"Evidence for serotonin receptor subtypes involvement in agmatine antidepressant like-effect in the mouse forced swimming test","volume":"1023","author":"Zomkowski","year":"2004","journal-title":"Brain Res"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584611003344?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584611003344?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T05:24:17Z","timestamp":1741929857000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584611003344"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":64,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S0278584611003344"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2011.11.005","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]}}}